Novartis Transfers Apligraf

December 15, 2002

Boston - Although officials are mum on details, product quality appears to be one factor in the transfer of worldwide marketing of Apligraf from Novartis Inc. back to Organogenesis, which develops the engineered skin and is solely responsible for its manufacture.

Related Content:

News